Improved Outcomes in Intermediate- and High-Risk Aggressive Non-Hodgkin Lymphoma after Autologous Hematopoietic Stem Cell Transplantation Substituting Intravenous for Oral Busulfan in a Busulfan, Cyclophosphamide, and Etoposide Preparative Regimen
2006 ◽
Vol 12
(7)
◽
pp. 770-777
◽
2014 ◽
Vol 20
(2)
◽
pp. S162-S163
2011 ◽
Vol 17
(4)
◽
pp. 586-587
◽
2020 ◽
Vol 26
(3)
◽
pp. S159
2010 ◽
Vol 16
(2)
◽
pp. 223-230
◽
2014 ◽
Vol 28
(6)
◽
pp. 1073-1095
◽
2010 ◽
Vol 16
(2)
◽
pp. S166
◽
2019 ◽
Vol 60
(10)
◽
pp. 2464-2470
◽